Microinjectrode System for Combined Drug Infusion and Electrophysiology
November 13th, 2019
9.2K views
We present a microinjectrode system designed for electrophysiology and assisted delivery of experimental probes (i.e., nanosensors, microelectrodes), with optional drug infusion. Widely available microfluidic components are coupled to a cannula containing the probe. A step-by-step protocol for microinjectrode construction is included, with results during muscimol infusion in macaque cortex.
Overview
This study presents a microinjectrode system tailored for drug infusion, electrophysiology, and the delivery of experimental probes like microelectrodes and nanosensors. The system minimizes tissue damage, allowing for repeated use in awake, behaving animals. A protocol for constructing the microinjectrode and results from a muscimol infusion in macaque cortex are detailed.
Key Study Components
Area of Science
- Electrophysiology
- Neuroscience
- Microfluidics
Background
- Traditional methods may compromise fragile probes when penetrating the dura mater.
- Existing techniques can cause significant tissue damage during insertion.
- Repeated use of microinjectrodes is critical for longitudinal studies in living animals.
- Microfluidics allows precise delivery of small volumes, essential for drug infusion strategies.
Purpose of Study
- To develop a versatile microinjectrode system for various applications.
- To facilitate the safe delivery of probes into brain tissue.
- To enable controlled drug infusion with minimal tissue impact.
Methods Used
- The study utilizes a custom microinjectrode system involving a cannula and microfluidic components.
- It employs a biological model using macaque cortex for drug infusion experiments.
- The protocol outlines detailed assembly and insertion procedures of the microinjectrode.
- Key steps include preparing the microelectrode, verifying leak-free assembly, and conducting drug infusions.
Main Results
- Successful infusion of a GABA A agonist resulted in reversible inactivation of the frontal eye field, monitoring the effects during a memory-guided saccade task.
- The microinjectrode maintained structural integrity while allowing precise probe placement.
- The microfluidic system effectively delivered drugs in the nanoliter scale.
- Key findings highlight the improved application of microinjectrodes for various electrophysiological experiments.
Conclusions
- This microinjectrode system demonstrates enhanced capabilities for drug delivery and electrophysiological measurements in vivo.
- The adaptations allow researchers to explore neuronal mechanisms with less tissue damage and improved data integrity.
- The findings have significant implications for future studies on neuronal activities and drug effects in behaving animals.
Frequently Asked Questions
What are the advantages of using the microinjectrode system?
The microinjectrode system minimizes tissue damage while allowing for repeated use in awake, behaving animals, which is essential for longitudinal studies.
How is the experimental probe inserted using the microinjectrode?
The probe is loaded into the cannula to ensure protection during insertion, which is critical when penetrating the dura mater.
What types of outcomes can be measured with this system?
The system allows for precision in drug infusion and real-time electrophysiological recordings from neural tissue, enabling detailed studies of neuronal responses.
Can this method be adapted for other types of experiments?
Yes, the microinjectrode can be configured for various experimental needs, including different types of probes or drug infusions tailored for specific studies.
What are potential limitations of the microinjectrode system?
Considerations include ensuring the system remains leak-free during assembly and handling specific handling procedures to avoid damage to fragile probes.
Executive Industry Relevance
The microinjectrode system enables precise, minimally invasive drug infusion and electrophysiological recording in awake, behaving animal models, supporting translational neuroscience and neuropharmacology pipelines. Its ability to deliver nanoliter-scale volumes and protect fragile probes advances mechanistic de-risking and target validation in preclinical research. This platform enhances predictive confidence for CNS drug discovery by enabling controlled, repeatable interventions and real-time neural monitoring.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Facilitates interrogation of neural circuit function through localized drug delivery and electrophysiological readouts.
- Enables reversible inactivation or modulation of specific brain regions to clarify target engagement.
- Supports mechanistic de-risking by allowing direct measurement of drug effects on neural activity and behavior.
Screening & Assay Development
- Prepares validated in vivo models for compound evaluation with integrated drug infusion and neural recording.
- Delivers quantitative, reproducible electrophysiological and behavioral outputs for assay standardization.
- Supports screening of CNS-active compounds by enabling simultaneous probe placement and drug administration.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant neural circuits and behavioral endpoints.
- Enables continuity from discovery through preclinical validation by supporting repeated, minimally invasive interventions.
- Provides translational biomarker data through combined behavioral and electrophysiological measurements.
Pipeline & Workflow Integration
This system integrates into the discovery-to-preclinical continuum, bridging target validation, mechanistic studies, and translational model development for CNS drug programs.
- Discovery Biology: Supports hypothesis testing and pathway clarification via localized, reversible neural modulation.
- Screening: Enables reproducible, quantitative in vivo assays for compound evaluation.
- Analytics: Provides high-resolution electrophysiological and behavioral data for comparative analysis.
- Translational Research: Facilitates alignment of preclinical endpoints with clinical biomarker strategies.
- Enterprise Reuse: Offers a flexible, reusable platform adaptable to diverse neural targets and probe types.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS target validation.
- Operational Value: Standardizes minimally invasive, repeatable procedures for in vivo neural interrogation.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling robust, translationally relevant data generation.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS assets through enhanced preclinical evidence.
Implementation Considerations
- Requires expertise in microfluidics, electrophysiology, and in vivo neuroscience techniques.
- Demands precise assembly and rigorous leak testing to ensure system integrity.
- Needs cross-team standardization for probe handling and data acquisition protocols.
- Adaptable to various brain regions and species of rodent size or larger, as supported by the source.
- Routine flushing and maintenance are critical to prevent obstructions and preserve system performance.
Biopharma FAQs
Why is null hypothesis testing critical for drug infusion effects?
Null hypothesis testing enables objective assessment of whether localized drug infusion via the microinjectrode produces statistically significant changes in neural activity or behavior, supporting robust target validation and mechanistic de-risking in CNS discovery pipelines.
How does independent variable isolation occur during probe and drug delivery?
The system allows precise, independent control of drug infusion and probe placement, ensuring that observed electrophysiological or behavioral changes can be attributed to the specific intervention, which is essential for discovery-stage mechanistic studies.
What do quantitative dependent variable measurements enable in this workflow?
Quantitative electrophysiological and behavioral outputs provide reproducible, high-resolution data for comparing drug effects across conditions, enabling reliable assay development and cross-study benchmarking in preclinical CNS research.
Why are replication requirements important for cross-functional teams using this system?
Replication ensures that observed neural and behavioral effects are robust and reproducible, facilitating collaboration between pharmacology, neuroscience, and translational teams and supporting enterprise-level decision-making.
What statistical analysis capabilities are needed before implementing microinjectrode studies?
Teams must be equipped to perform rigorous statistical comparisons of neural and behavioral data, including baseline versus post-infusion conditions, to validate findings and inform risk-adjusted advancement decisions in the CNS pipeline.
Chapters in this video
0:04
Title
0:46
Construction of the Microinjectrode for Stimulation and Recording
2:21
Microfluidic System
3:22
Preparation of the Microfluidic System
5:46
Performing Recording for an Infusion Experiment
6:38
Results: Memory Guided Saccade Task during Muscimol Infusion in FEF (Frontal Eye Field)
7:26
Conclusion
